Pictet Alternative Advisors logo

Pictet Alternative Advisors

Europe, Geneve, Switzerland, Geneva

Description

Pictet Alternative Advisors (PAA) is a European alternative investment specialist.

Investor Profile

Pictet Alternative Advisors has made 7 investments, with 2 in the past 12 months and 14% as lead.

Stage Focus

  • Series C (71%)
  • Series A (14%)
  • Series B (14%)

Country Focus

  • United States (86%)
  • United Kingdom (14%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Life Science
  • Therapeutics
  • Medical Device
  • Health Diagnostics
  • Product Research
  • Manufacturing
  • Analytics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pictet Alternative Advisors frequently co-invest with?

Solasta Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
4BIO Capital
Europe, England, United Kingdom, London
Co-Investments: 1
MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Livzon Pharmaceutical Group
Asia, Guangdong, China, Zhuhai
Co-Investments: 1
Penn Medicine Co-Investment Program
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 1
AbbVie
North America, Illinois, United States, North Chicago
Co-Investments: 1

What are some of recent deals done by Pictet Alternative Advisors?

Atalanta Therapeutics

Boston, Massachusetts, United States

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.

BiotechnologyHealth CareLife Science
Series BJan 28, 2025
Amount Raised: $97,000,000
Caresyntax

Boston, Massachusetts, United States

Caresyntax is a vendor neutral data-driven surgery platform that makes surgery smarter by reducing variability and improving efficency.

AnalyticsArtificial Intelligence (AI)Data VisualizationHealth CareMedicalSoftware
Series CAug 15, 2024
Amount Raised: $80,000,000
Clasp Therapeutics

Cambridge, Massachusetts, United States

Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.

BiotechnologyTherapeutics
Series AMar 20, 2024
Amount Raised: $150,000,000
Generate Biomedicines

Somerville, Massachusetts, United States

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.

BiotechnologyHealth CareMedicalProduct Research
Series CSep 15, 2023
Amount Raised: $273,000,000
Pulmocide

London, England, United Kingdom

Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.

BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device
Series CDec 6, 2022
Amount Raised: $52,000,000
Carisma Therapeutics

Philadelphia, Pennsylvania, United States

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series CSep 21, 2022
Amount Raised: $30,000,000
JenaValve Technology

Irvine, California, United States

JenaValve is a medical device company focused on the design and development of innovative transcatheter heart valve solutions

Health CareManufacturingMedical Device
Series CAug 31, 2022
Amount Raised: $100,000,000